filmov
tv
John Teerlink, MD: Impact of COVID-19 on Clinical Trials
Показать описание
Professor of Medicine and Executive Committee Chair, COSMIC-HF and GALACTIC-HF discusses impact of COVID-19 on clinical trials.
HCPLive
covid-19
clincal trials
fda
Рекомендации по теме
0:03:56
John Teerlink, MD: Impact of COVID-19 on Clinical Trials
0:07:17
John Teerlink, MD: GALACTIC-HF Patient Population
0:08:49
The Relax-AHF-2 Trial: Dr John Teerlink (HFA Congress 2017 - Paris)
0:04:36
#HFSA2019 TV: Interview with John Teerlink, MD
0:08:18
Serelaxin in Acute Heart Failure
0:08:45
Late Breaking Trials on Heart Failure and Acute Coronary Syndrome: J. TEERLINK (San Francisco):
0:07:04
J. Teerlink - The RELAXin in Acute Heart Failure (RELAX-AHF-1) Trial
0:09:15
COSMIC-HF: Omecamtiv Mecarbil in Chronic Heart Failure
0:05:39
GALACTIC-HF Results
0:04:29
AHA 2015 | COSMIC-HF
1:08:11
Webinar 'Landmark trials in heart failure'
0:02:01
The impact of COVID-19 on clinical research and development
0:00:57
Hyperkalemia TV: A Team Mindset for Optimizing HF Therapy
0:06:59
ESC TV 2013 - Hotline IV: AQUARIUS and ATOMIC AHF
0:50:31
Webinar | JACC: Heart Failure December Virtual Journal Club - Discussion on the STAND-UP AHF Study
0:29:48
Professor John McMurray - Heart failure therapy – extending the limits!
0:55:54
Episode 6: Implications of the Advisory Committee Meetings for the Heart Failure Community
0:51:05
JACC: Heart Failure Journal Club | June 18, 2020
0:01:26
RELAX-AHF-2 Serelaxin in acute heart failure
0:11:31
New Medication Shows Early Promise for Heart Failure Treatment
1:00:44
Endpoints in Heart Failure Clinical Trials: Challenges and Potential Resolutions
0:02:56
GALACTIC-HF Subgroup Analysis: Omecamtiv Mecarbil Effective Across Ethnic Groups | Dr David Lanfear
0:04:05
GALACTIC HF Trial: Omecamtiv mecarbil
0:06:19
Spotlight On...COVID-19’s Impact on Quality in Clinical Trials